CASP9 and lip and oral cavity carcinoma: Furthermore, treatment with the same compound in the study conducted by Qiao et al. [34] involving oral cancer xenografts in adult Wistar rats resulted in a reduced expression of Bcl-2 protein with a corresponding elevation in the Bax levels and caspase 9 activity.